Bingham Kathleen S, Rozenbojm Nathalie, Chong-East Mariah, Touma Zahi
University of Toronto and Toronto General Hospital, Toronto, Ontario, Canada.
Toronto Western Hospital, Toronto, Ontario, Canada.
ACR Open Rheumatol. 2021 Jan;3(1):25-33. doi: 10.1002/acr2.11205. Epub 2020 Dec 13.
Although the coronavirus disease 2019 (COVID-19) pandemic has been associated with increased psychological distress globally, it poses unique challenges to persons who are potentially more vulnerable to its effects, including patients with autoimmune disease. In this article, we review the published literature and media reports to determine factors that may contribute to mental health challenges in persons with autoimmune disease. We then explore existing mental health interventions that have been developed for use in COVID-19 and in patients with autoimmune disorders in general. We identified several potential contributors to psychological distress in patients with autoimmune disease during the pandemic, as follows: feelings of discrimination related to societal response to COVID-19, fear of infection and uncertainty related to immunosuppressive medication, diminished access to usual care and resources, previous health-related trauma, and the exacerbating effect of social isolation. Drawing from existing literature, we synthesize the identified evidence to develop a proposed framework for researching and managing mental health challenges in autoimmune disease during the pandemic and its aftermath.
尽管2019冠状病毒病(COVID-19)大流行在全球范围内导致心理困扰加剧,但它给可能更容易受到其影响的人群带来了独特挑战,包括自身免疫性疾病患者。在本文中,我们回顾已发表的文献和媒体报道,以确定可能导致自身免疫性疾病患者心理健康挑战的因素。然后,我们探讨了针对COVID-19以及一般自身免疫性疾病患者所开发的现有心理健康干预措施。我们确定了大流行期间自身免疫性疾病患者心理困扰的几个潜在因素,如下:与社会对COVID-19的反应相关的歧视感、对感染的恐惧以及与免疫抑制药物相关的不确定性、获得常规护理和资源的机会减少、既往与健康相关的创伤,以及社会隔离的加剧作用。我们借鉴现有文献中的证据,综合已确定的证据,以制定一个拟议框架,用于研究和管理大流行期间及其后果中自身免疫性疾病患者的心理健康挑战。